Nearly 50 percent of colorectal cancer survivors have continued pain interference
the ONA take:
According to a recent study published in the journal Pain Medicine, researchers from the University of Alabama at Birmingham have found that almost half of colorectal cancer survivors with pain interference during the initial phase of care have continued pain interference after treatment.
For the study, researchers analyzed survey results from participants with colorectal cancer of the Cancer Care Outcomes Research and Surveillance Consortium during the initial phase of care and follow-up.
They identified 2,961 patients during the initial phase and 2,303 patients during follow-up. Results showed that at baseline, 24.7% of participants reported moderate and high pain interference compared with 23.7% during follow-up.
For 46% of participants with baseline pain interference, pain interference was either the same or worse at follow-up.
Researchers found that chemotherapy, comorbidities, depression, female gender, and radiation were associated with moderate and high pain interference at the time of diagnosis and during follow-up. On the other hand, older age was associated with improved pain interference.
The study also showed that those pulmonary disease or heart failure comorbidities had equivalent or increasing pain interference at follow-up.
Almost half of colorectal cancer survivors with pain interference during the initial phase of care have continued pain.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- ONS Partners with ASCO CancerLinQ to Launch CancerLinQ® Ambassadors Program
- Characteristics of Clinical Trials and Barriers to Patient Enrollment Identified
- Exercise Improves Coping While Undergoing Chemotherapy for Advanced GI Cancer
- Genetic Similarity to BRCA1/BRCA2 Mutations May Impact Treatment Options
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|